Related Experiment Video
Updated: Nov 16, 2025
04:24
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
12.1K
A Novel User Utility Score for Diabetes Management Using Tailored Mobile Coaching: Secondary Analysis of a Randomized
Min-Kyung Lee1, Da Young Lee2, Hong-Yup Ahn3
1Division of Endocrinology and Metabolism, Department of Internal Medicine, Myongji Hospital, Hanyang University College of Medicine, Gyeonggi-do, Republic of Korea.
JMIR Mhealth and Uhealth
|February 24, 2021
Summary
A novel user utility score (UUS) effectively measures patient engagement in mobile health diabetes management. Higher UUS scores correlate with improved glycemic control, demonstrating the value of tailored interventions for type 2 diabetes.
Area of Science:
- Digital Health
- Endocrinology
- Behavioral Science
Background:
- Mobile health (mHealth) apps aim to improve diabetes self-management.
- Patient engagement is crucial for mHealth app effectiveness.
- Tailored behavioral interventions are key to individual patient engagement.
Purpose of the Study:
- To evaluate a novel user utility score (UUS) for measuring patient engagement.
- To assess the UUS's utility in a mobile health application for diabetes management.
Main Methods:
- A subanalysis of a 12-month randomized controlled trial involving a tailored mobile coaching (TMC) system.
- UUS calculated based on self-monitoring blood glucose, diet/exercise records, and message engagement.
- Exploration of UUS association with glycemic control, blood pressure, lipids, and self-management scales.
Main Results:
- Participants with higher UUS (5-8) showed significantly greater HbA1c reduction compared to lower UUS (0-4) [-0.92% vs -0.33%].
- UUS was significantly associated with improved HbA1c at 3, 6, and 12 months (P=.006, P=.002, P=.011).
- No significant differences in blood pressure or lipid profiles were observed between groups.
Conclusions:
- The UUS is a valid measure of patient engagement in mHealth diabetes interventions.
- UUS can predict improved glycemic control in type 2 diabetes management.
- This highlights the potential of mHealth and tailored interventions for diabetes self-management.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
697
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
697
01:22Diabetes Mellitus: Type 2 and Gestational
3.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K